Modalities of prescription of biochemical markers of bone turnover in French hospitals;Enquête sur la prescription des marqueurs du remodelage osseux en milieu hospitalier

Annales de Biologie Clinique

Volumn 60, Issue 5, 2002, Pages 571-579

  Souberbielle, J C ^a   Carlier, M C ^a   Bianchi, F ^a   Genty, V ^a   Jacob, N ^a   Kamel, S ^a   Kindermans, C ^a   Plouvier, E ^a   Pressac, M ^a   Garnero, P ^a  

^a INSERM   (France)

Author keywords

Bone formation; Bone pathology; Bone resorption; Marker of bone turnover; Osteoporosis

Indexed keywords

ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; BISPHOSPHONIC ACID DERIVATIVE; CALCIFEDIOL; CALCITRIOL; CALCIUM; CALCIUM ION; DEOXYPYRIDINOLINE; ESTROGEN; HYDROXYPROLINE; OSTEOCALCIN; PARATHYROID HORMONE; PYRIDINOLINE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; VITAMIN D;

AGED; ARTICLE; BONE DISEASE; BONE TURNOVER; CLINICAL LABORATORY; ESTROGEN THERAPY; FRACTURE; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MEASUREMENT; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; POSTMENOPAUSE OSTEOPOROSIS; PRESCRIPTION; RHEUMATIC DISEASE;

BIOLOGICAL MARKERS; BONE REMODELING; EDUCATION, MEDICAL, CONTINUING; FRANCE; GUIDELINE ADHERENCE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MEDICAL STAFF, HOSPITAL; NEEDS ASSESSMENT; OSTEOPOROSIS; PATIENT SELECTION; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PRESCRIPTIONS, NON-DRUG; QUESTIONNAIRES; SPECIALTIES, MEDICAL;

EID: 18644368872     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Watts N. Biochemical markers of bone turnover. Clin Chem 1999; 45: 1359-68.
2. Delmas PD. Utilisation des marqueurs biologiques osseux dans l'ostéoporose post-ménopausique. Ann Biol Clin 2001; 59: 299-308.
3. Vignot E, Meunier PJ. Utilisation des marqueurs du remodelage osseux dans la maladie de Paget. Ann Biol Clin 2001; 59: 309-11.
4. Ureña P. Marqueurs biologiques osseux dans l'insuffisance rénale. Ann Biol Clin 2001; 59: 313-6.
5. Miller P, Baran D, Bilezikian J, et al. Practical application of biochemical markers of bone turnover. Consensus of an expert panel. J Clin DensitometrY 1999; 2: 323-42.
6. Garnero P, Bianchi F, Carlier MC, et al. Les marqueurs biologiques du remodelage osseux: variations préanalytiques et recommendations pour leur utilisation. Ann Biol Clin 2000; 58: 683-704.
7. Vesper H, Demers L, Eastell R, et al. Assessment and recommendations on factors contributing to preanalytical variability of urinary pyridinoline and deoxypyrydinoline. Clin Chem 2000; 48: 220-34.
8. Delmas PD, Eastell R, Garnero P, Seibel M, Stepan J. The use of biochemical markers of bone turnover in osteoporosis. Osteoporosis Int 2000; 11 (Suppl. 6): S2-17.
9. Nishizawa Y, Nakamura T, Ohata H, et al., Guideline on the use of biochemical markers of bone turnover in osteoporosis (2001). J Bone Miner Metab 2001; 19: 338-44.
10. Blumsohn A, Naylor K, Assiri AM, Eastell R. Different responses in biochemical markers of bone resorption to bisphosphonate therapy in Paget's disease. Clin Chem 1995; 41: 1592-8.
11. Garnero P, Gineyts E, Arbault P, Christiansen C, Delmas P. Different effects of bisphosphonate and estrogen therapy on free and peptidebound bone cross-links excretion. J Bone Miner Res 1995; 10: 641-9.
12. Randall DH, Prince RL, Stewart G, et al. Comparison of biochemical markers of bone turnover in Paget disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline cross-links. J Bone Miner Res 1996; 11: 1176-84.
13. Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001; 344: 1434-41.
14. Fontana A, Garnero P, Delmas P. markers of bone turnover in diagnosis and monitoring of bone metastases. In: Body JJ, ed. Tumor bone disease and osteoporosis in cancer patients., New York: Marcel Dekker, 1999: 213-26.
15. Garnero P. Markers of bone turnover in prostate cancer. Cancer Treat Rev 2001; 27: 187-92.
16. Hannon R, Eastell R. Preanalytical variability of biochemical markers of bone turnover. Osteoporosis Int 2000; 11 (Suppl. 6): S30-44.
17. Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med 2001; 135: 825-34.